APA (7th ed.) Citation

Velázquez, G. F., Anand, P., Abdulmajid, J., Feng, X., Weller, J. F., Hirschbühl, K., . . . Schmid, C. Clinical stabilization of a highly refractory acute myeloid leukaemia under individualized treatment with immune response modifying drugs by in vivo generation of dendritic cells of leukaemic origin (DCleu) and modulation of effector cells and immune escape mechanisms. BMC.

Chicago Style (17th ed.) Citation

Velázquez, Giuliano Filippini, Philipp Anand, Joudi Abdulmajid, Xiaojia Feng, Jan Frederic Weller, Klaus Hirschbühl, Helga Schmetzer, and Christoph Schmid. Clinical Stabilization of a Highly Refractory Acute Myeloid Leukaemia Under Individualized Treatment with Immune Response Modifying Drugs by in Vivo Generation of Dendritic Cells of Leukaemic Origin (DCleu) and Modulation of Effector Cells and Immune Escape Mechanisms. BMC.

MLA (9th ed.) Citation

Velázquez, Giuliano Filippini, et al. Clinical Stabilization of a Highly Refractory Acute Myeloid Leukaemia Under Individualized Treatment with Immune Response Modifying Drugs by in Vivo Generation of Dendritic Cells of Leukaemic Origin (DCleu) and Modulation of Effector Cells and Immune Escape Mechanisms. BMC.